CD274 and neoplasm: In addition, Teng et al.28 reported a simplistic and pragmatic stratification of the tumor immune microenvironment (TIME) according to the presence of TILs and PD-L1 expressions, in which dual positive (PD-L1+/TIL+) tumors are most likely to benefit from anti-PD-1/PD-L1 antibodies.